Clinical trial
Lucentis Utilizing Visudyne (LUV Trial) Combination Therapy in the Treatment of…
NCT00423189 · David M. Brown, M.D., Other · Terminated
Key facts
| NCT number | NCT00423189 |
|---|---|
| Title | Lucentis Utilizing Visudyne (LUV Trial) Combination Therapy in the Treatment of Age-Related Macular Degeneration |
| Official title | Lucentis Utilizing Visudyne (LUV Trial)-- Reduced Fluence Photodynamic Therapy With Visudyne Combined With Intravitreal Ranibizumab in the Treatment of Age-Related Macular Degeneration |
| Lead sponsor | David M. Brown, M.D., Other |
| Collaborators | Novartis Pharmaceuticals Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Age-Related Macular Degeneration |
| Intervention type | Drug |
| Interventions | Ranibizumab (Lucentis), 0.5mg ranibizumab |
| Enrollment | 7 |
| Start date | Jan 1, 2007 |
| Primary completion | Jan 1, 2009 |
| Completion | Jan 1, 2009 |
| First posted | Jan 18, 2007 |
| Last update posted | Mar 4, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: